Metabolism alternation of schisandra chinensis in carbon tetrachloride-intoxicated rats and patients with advanced hepatocellular carcinoma
- Author:
Rong-Rong WU
1
;
Zhi-Yong XIAO
;
Xiao-Rui ZHANG
;
Feng LIU
;
Wen-Xia ZHOU
;
Yong-Xiang ZHANG
Author Information
1. State Key Laboratory of Toxicology and Medical Countermeasures
- Keywords:
schisandra chinensis;
lignans;
pharmacokinetics;
liver injury;
cytochrome P450
- From:
Chinese Journal of Pharmacology and Toxicology
2018;32(4):314-314
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To study the pharmacokinetics change of schisandra chinensis under the pathological condition of liver dysfunction for safe and rational use of herbal medicines. METHODS The metabolism of four effective lignans from schisandra chinensis(SC), schisandrin,schisantherin A, deoxyshisandrin and γ-schisandrin was studied using microsomes from patients with advanced hepato-cellular carcinoma. In situ intestinal and hepatic perfusions were conducted to clarify the contributions from impairments of gut and liver on the pharmacokinetics of the four schisandra lignans in CCl4-intoxi-cated rats.The metabolism in rat and human liver microsomes and transport in Caco-2 monolayer cell model were studied to reveal the key factors for the in vivo disposition of the four lignans. RESULTS When SC alcoholic extract was orally administrated to CCl4-intoxicated rat for a short term (4 d), the pharmacokinetics of four active SC lignans was significantly changed while its hepatoprotective effect was not obviously observed.The plasma concentrations of the four schisandra lignans were dramatical-ly elevated compared with the control.The Cmax,AUC and MRT were all increased or prolonged signif-icantly while parameter CLz/F was obviously reduced in rat pretreated with CCl4. In hepatic perfusion study and liver microsomes incubation,it was found that the hepatic metabolism of the four lignans was markedly decreased mainly due to the activity reduction of multiple CYP450 isoenzymes involved the metabolism, which, eventually, might lead to the alternation of their pharmacokinetic profiles in CCl4-intoxicated rats or patients with advanced hepatocellular carcinoma. CONCLUSION The pharmacoki-netic studies of SC components in pathological situation of liver dysfunction are expected to provide useful data for rational and safe application of SC preparations in clinic or further pharmacological and toxicological research.
